Oruka Therapeutics, Inc. ORKA Issuance Of Common Stock Under Employee Stock Purchase Plan And Exercise Of Options And Warr
Issuance Of Common Stock Under Employee Stock Purchase Plan And Exercise Of Options And Warr at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept orka:IssuanceOfCommonStockUnderEmployeeStockPurchasePlanAndExerciseOfOptionsAndWarr.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s issuance of common stock under employee stock purchase plan and exercise of options and warr.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s issuance of common stock under employee stock purchase plan and exercise of options and warr?
- Oruka Therapeutics, Inc. (ORKA) reported issuance of common stock under employee stock purchase plan and exercise of options and warr of $73.5K in Q4 2025.
- What does issuance of common stock under employee stock purchase plan and exercise of options and warr mean?
- This metric represents the cash inflows resulting from the exercise of stock options, warrants, or participation in employee stock purchase plans. It reflects the capital raised through equity-based compensation programs and employee equity participation. Investors monitor this to assess potential dilution and the extent to which employees are exercising their equity incentives.